Immune Response Following Seasonal Influenza Vaccination
Clinical trial NCT03163342 · COMPLETED
Trial details
- NCT number
- NCT03163342
- Sponsor
- Altimmune, Inc.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-08
- Primary completion
- 2017-11-21
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.